Cryoablation Technology Now Available for Cancer Treatment in India, Offering New Hope for Patients
Mumbai (Maharashtra), June 9 – Cancer patients in India can now find relief with the introduction of cryoablation technology, a minimally invasive and highly effective treatment for various types of tumors. Cryoablation utilizes extreme cold to freeze and destroy diseased tissue with precision, offering a less invasive alternative to traditional treatment methods. This cutting-edge technology, developed by the Israeli company IceCure Medical, has been made available in India by NovoMed Incorporation Pvt Ltd, the authorized distributor of IceCure Medical’s Pro-Sense device.
What is Cryoablation and How Does It Work?
Cryoablation is an image-guided treatment (using ultrasound or CT scan) that involves inserting a thin, needle-like probe called a cryoprobe into the target tumor area. The cryoprobe is cooled with liquid nitrogen (LN2), which rapidly freezes the surrounding tissue. As the tissue freezes, ice crystals form within the cells, causing cellular damage and ultimately leading to the destruction of abnormal tissue. This method is effective in targeting both benign and malignant tumors with minimal pain and recovery time.
Advantages of Cryoablation Over Other Treatments
Cryoablation offers several advantages over traditional treatment methods. As a minimally invasive procedure, it requires only a small incision or needle puncture, resulting in less trauma to the body and faster recovery compared to open surgery. Cryoablation can often be performed under local anesthesia, eliminating the need for general anesthesia in many cases. This precision-targeted treatment helps destroy abnormal tissue while preserving surrounding healthy tissue, making it a highly effective option for patients.
In many cases, a hospital stay is not required, allowing patients to return to their normal activities sooner. Cryoablation has proven to be particularly effective for treating a variety of tumors, including those found in the breast, kidneys, liver, lungs, bones, soft tissues, and other types of cancers.
Expert Insights on Cryoablation in India
Dr. Bhavin Jankharia, a Consultant Radiologist, shared his positive experience with the IceCure machine, stating, “My experience using the IceCure machine has been excellent. The results have been good, and we receive great support from Jay, Prashant, and their team, which makes the process much easier for both the patients and the medical professionals. Cryoablation fills a vital niche in the ablation space, particularly for fibromatosis and specific bone and soft tissue tumors.”
Dr. Vimal Someshwar, an Interventional Radiologist at Kokilaben Dhirubai Ambani Hospital, also commented, “Cryoablation has shown excellent results in pain management and is highly effective for tumor treatment. This technology has tremendous potential and may expand its applications in the future.”
Expanding Access to Cryoablation Technology in India
The cryoablation therapy was recently introduced at Kovai Medical Center in Coimbatore, marking a significant step forward in providing advanced cancer treatment options in India. Jay Mehta, Director of Sales at NovoMed Incorporation Pvt Ltd, expressed his enthusiasm, saying, “We are thrilled to bring this futuristic and revolutionary technology to India. The Indian population should take full advantage of this technology to combat cancer effectively and freeze tumors in their tracks.”
Conclusion
Cryoablation technology offers hope to cancer patients by providing a minimally invasive, precise, and effective treatment method for a variety of tumors. With the availability of IceCure’s Pro-Sense device in India, patients now have access to a state-of-the-art solution that can improve outcomes and speed up recovery times. As the technology gains traction, it has the potential to revolutionize cancer treatment in India and beyond.
For more information, please contact NovoMed Incorporation Pvt Ltd.
For any concerns or feedback regarding this press release, please contact [email protected]. We will respond and rectify any issues within 24 hours.
